Valuation (24%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.19 | 2.60 |
| PEG Ratio (TTM) | 0.04 | 1.13 |
| P/S Ratio (TTM) | 0.05 | 1.40 |
| P/B Ratio (TTM) | -0.07 | 2.20 |
| P/FCF Ratio (TTM) | -0.66 | 18.10 |
| Price to 5YR AVG Earnings Ratio | -0.79 | -86.22 |
| Price to 5YR AVG FCF Ratio | -7.45 | 17.02 |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -23.44% | 1.16% |
| ROE (TTM) | 38.70% | 17.31% |
| Net Profit Margin (TTM) | -24.97% | 1.69% |
| ROIC 5YR AVG | 2.23% | 18.68% |
Growth (52%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -70.17% | 259,982.33% | 155,882.15% |
| Revenue | -3.75% | N/A | 3.95% |
| Net Income | -26.84% | 9,784.60% | 5,757.51% |
| Cash Flow | -0.63% | 1,113.86% | 167.67% |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.15 | 1.21 |
| Quick Ratio (TTM) | 1.15 | 1.17 |
| D/E Ratio (TTM) | -2.57 | 1.00 |
| Interest Coverage (TTM) | -3.17 | 4.83 |
| Piotroski F-Score | 2 | 6 |
| Altman Z-Score | 0.13 | 2.16 |
| LTL to 5YR AVG FCF | -255.43 | 5.42 |
| Shares Outstanding Growth 5YR AVG | -9.74% | 2.87% |